cancer clinical trials in oregon city, OR
Willamette Falls Hospital
Oregon City, Oregon 97045 Breast Cancer
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Colorectal Cancer
|
GSK Investigational Site
Oregon City, Oregon 97045 Prophylaxis for HPV Infections and Associated Cervical Neoplasia
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Breast Cancer
|
GSK Investigational Site
Oregon City, Oregon 97045 Lung Cancer, Non-Small Cell
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Lung Cancer
|
GSK Investigational Site
Oregon City, Oregon 97045 Lung Cancer, Non-Small Cell
|
GSK Investigational Site
Oregon City, Oregon 97045 Neoplasms, Breast, Breast Cancer
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Lung Cancer
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 Neuroendocrine Carcinoma
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
|
Willamette Falls Community Hospital
Oregon City, Oregon 97045 Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
GSK Investigational Site
Oregon City, Oregon 97045 Neoplasms, Breast
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
|
GSK Investigational Site
Oregon City, Oregon 97045 Carcinoma, Renal Cell
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Malignant Mesothelioma
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Extrahepatic Bile Duct Cancer, Gallbladder Cancer
|
GSK Investigational Site
Oregon City, Oregon 97045 Melanoma
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Lymphoma
|
Willamette Falls Community Hospital
Oregon City, Oregon 97045 Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
|
GSK Investigational Site
Oregon City, Oregon 97045 Neoplasms, Breast
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
|
GSK Investigational Site
Oregon City, Oregon 97045 Leukemia-relapsed or Refractory, Cancer
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Colorectal Cancer, Precancerous Condition
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Malignant Mesothelioma
|
Willamette Falls Hospital
Oregon City, Oregon 97045 brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
|
GSK Investigational Site
Oregon City, Oregon 97045 Thrombocytopaenia
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Colorectal Cancer
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 Light Chain Deposition Disease, Smoldering Multiple Myeloma
|
GSK Investigational Site
Oregon City, Oregon 97045 Neoplasms, Breast
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
|
GSK Investigational Site
Oregon City, Oregon 97045 Cancer
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Breast Cancer, Depression, Fatigue, Sleep Disorders
|
GSK Investigational Site
Oregon City, Oregon 97045 Lymphoma, Non-Hodgkin
|
GSK Investigational Site
Oregon City, Oregon 97045 Lung Cancer, Non-Small Cell
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Cancer
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Arthralgia, Breast Cancer, Pain
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Lymphoma
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Colorectal Cancer
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Breast Cancer
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 Breast Cancer
|
GSK Investigational Site
Oregon City, Oregon 97045 Melanoma
|
GSK Investigational Site
Oregon City, Oregon 97045 Non-Small-Cell Lung Cancer, Lung Cancer, Non-Small Cell
|
GSK Investigational Site
Oregon City, Oregon 97045 Neoplasms, Breast
|
GSK Investigational Site
Oregon City, Oregon 97045 Constipation, Bowel Dysfunction
|
GSK Investigational Site
Oregon City, Oregon 97045 Papillomavirus Infection
|
GSK Investigational Site
Oregon City, Oregon 97045 Human Papillomavirus (HPV) Infection, Cervical Neoplasia
|
GSK Investigational Site
Oregon City, Oregon 97045 Neoplasms, Prostate, Prostate Cancer
|
GSK Investigational Site
Oregon City, Oregon 97045 Neoplasms, Breast
|
GSK Investigational Site
Oregon City, Oregon 97045 Neoplasms, Breast
|
GSK Investigational Site
Oregon City, Oregon 97045 Neoplasms, Gastrointestinal Tract
|
GSK Investigational Site
Oregon City, Oregon 97045 Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Breast Cancer
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Lymphoma
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Lymphoma
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Lymphoma
|
Providence Willamette Falls Medical Center
Oregon City, Oregon 97045 Light Chain Deposition Disease, Primary Systemic Amyloidosis
|
Willamette Falls Hospital
Oregon City, Oregon 97045 Breast Cancer
|